Literature DB >> 4048209

Endotoxins and medical devices.

V C Ross, C W Twohy.   

Abstract

The FDA Center for Devices and Radiological Health requires devices in contact with circulating blood or cerebrospinal fluid to be nonpyrogenic. Intraocular lenses also are required to be nonpyrogenic. Requirements for other products are decided on a case-by-case basis by the FDA. Manufacturers planning to use the Limulus Amebocyte Lysate (LAL) test as a pyrogenicity test for devices must validate and test according to the FDA draft LAL guideline or submit data from an alternate method to FDA for review. Traditionally, nonpyrogenic water or saline is used to rinse devices for LAL testing. Data from our initial studies on endotoxin recovery from devices using sodium lauryl sulfate demonstrate higher recovery than with nonpyrogenic water. This method, which provides an alternate rinse solution for recovery of endotoxin from medical devices is undergoing collaborative study.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4048209

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  4 in total

1.  Adherent lipopolysaccharide inhibits the osseointegration of orthopedic implants by impairing osteoblast differentiation.

Authors:  Lindsay A Bonsignore; J Robert Anderson; Zhenghong Lee; Victor M Goldberg; Edward M Greenfield
Journal:  Bone       Date:  2012-09-17       Impact factor: 4.398

2.  Ambiguities in applying traditional Limulus amebocyte lysate tests to quantify endotoxin in nanoparticle formulations.

Authors:  Marina A Dobrovolskaia; Barry W Neun; Jeffrey D Clogston; Hui Ding; Julia Ljubimova; Scott E McNeil
Journal:  Nanomedicine (Lond)       Date:  2010-06       Impact factor: 5.307

Review 3.  Do genetic susceptibility, Toll-like receptors, and pathogen-associated molecular patterns modulate the effects of wear?

Authors:  Edward M Greenfield
Journal:  Clin Orthop Relat Res       Date:  2014-12       Impact factor: 4.176

4.  Surface contaminants inhibit osseointegration in a novel murine model.

Authors:  Lindsay A Bonsignore; Robb W Colbrunn; Joscelyn M Tatro; Patrick J Messerschmitt; Christopher J Hernandez; Victor M Goldberg; Matthew C Stewart; Edward M Greenfield
Journal:  Bone       Date:  2011-07-23       Impact factor: 4.398

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.